Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19.

ABSTRACT: Virus induced endothelial dysregulation is a well-recognised feature of severe Covid-19 infection. Endothelin-1 (ET-1) is the most highly expressed peptide in endothelial cells and a potent vasoconstrictor, thus representing a potential therapeutic target. ET-1 plasma levels were measured in a cohort of 194 Covid-19 patients stratified according to the clinical severity of their illness. Hospitalised patients, including those who died and those developing acute myocardial or kidney injury, had significantly elevated ET-1 plasma levels during the acute phase of infection. The results support the hypothesis that endothelin receptor antagonists may provide clinical benefit for certain Covid-19 patients.

SUBMITTER: Abraham GR 

PROVIDER: S-EPMC8941861 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature